Companies: 10,795·Total market cap: $144.5T

Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc.

KLTONASDAQHealthcare

$0.38

$-0.03(-7.10%)

Market Cap$20079881

P/E Ratio—

52W High$3.91

52W Low$0.114

Avg Volume3.2M

Open$0.41

Beta2.23

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Klotho Neurosciences, Inc.（KLTO）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · KLTO · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.33Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding19.2MShares outstanding history

Next EarningsTBAEarnings history

探索 Klotho Neurosciences, Inc. 数据

分析师预测—

股息不分红

盈利EPS $-0.32-45614.29%

财务快照

FY 2024Revenue$0.00

202220232024

FY 2024Net Income-$6.2M▼ 769.36% YoY

202220232024

FY 2024EPS$-0.32▼ 45614.29% YoY

202220232024

TTM:Revenue: $0.00Net Income: -$11.3MEPS: $-0.33View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Klotho Neurosciences, Inc.

$0.38-7.10%$20.1M #2

Cadrenal Therapeutics, Inc. Common Stock

$4.21-5.18%$12.1M #3

$1.73-4.95%$27.3M #4

$2.22-13.62%$4.9M #5

Minerva Neurosciences, Inc.

$4.63-6.65%$32.4M #6

NeuroSense Therapeutics Ltd.

$0.75+0.20%$18.5M

股票表现

1D+10.15%

1W-11.40%

1M-7.10%

3M+21.65%

YTD+31.83%

1Y+116.48%

5Y-63.01%

关于 Klotho Neurosciences, Inc.

CEOJoseph A. Sinkule

IPO DateApr 29, 2022

Employees3

CountryUS

Websiteklothoneuro.com

Klotho Neurosciences, Inc. operates as a biopharmaceutical enterprise focused on devising medical treatments for various conditions, including cancer, cardiovascular ailments, and neurodegenerative di…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Klotho Neurosciences, Inc.（KLTO）是 Biotechnology 行业的 Healthcare 类公司，于 Apr 29, 2022 在 NASDAQ 上市。截至最近交易日，KLTO 股价为 $0.38，市值约为 $20.1M。过去12个月累计回报 +116.48%，年初至今回报 +31.83%。

2024 财年 Klotho Neurosciences, Inc. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Klotho Neurosciences, Inc.（KLTO）股价为 $0.38，在 NASDAQ 上市，52周区间为 $0.11 – $3.91。

KLTO 最新股价KLTO quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议